Welcome to Cato Research

Cato Research is a full-service contract research and development organization with international resources dedicated to helping pharmaceutical and biotechnology companies efficiently and expeditiously navigate the regulatory approval process in order to bring new drugs, biologics, and medical devices to the people who need them.

» Cato Research Overview | Contact Us

Announcements

  • Cato Research has a new Blog! Visit us often to read timely posts from Cato Research professionals and their guests.

  • Cato Research is now using Twitter! Follow us to keep up to date on the latest Cato news and events.

Recent Posts

  • August 27, 2010 - Five Keys to Successful Adaptive Trials – Running adaptive trials is not easy. However, in a world of skyrocketing drug development costs, these trials are set to become essential tools in any drugmaker’s repertoire, especially early in clinical [...]

  • August 23, 2010 - CDRH Proposes Changes to the 510(k) Pathway – The Center for Devices and Radiological Health (CDRH) has been somewhat under fire in recent years, so it surprised no one when it undertook a long look in the mirror in 2009. With this period of [...]

  • August 20, 2010 - Important Steps Forward for Early Detection and Diagnose of Alzheimer's Disease – In a recent report by Geert De Meyer of Ghent University in Belgium and colleagues, titled “Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People” (Arch Neurol. 2010;67(8):949-956) it was demonstrated [...]

  • More Posts...